Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07555132
NA

Circulating Oxytocin Changes in Response to MDMA vs. Placebo in Adult Patients With Autism Spectrum Disorder and Matched Healthy Controls

Sponsor: University Hospital, Basel, Switzerland

View on ClinicalTrials.gov

Summary

This study is to investigate the physiological mechanism of oxytocin system stimulation using 3,4-methylenedioxymethamphetamine (MDMA) as a physiological tool (acute oxytocin releases), not as a medication. This study seeks to test whether the oxytocin response after MDMA administration is different between individuals with autism spectrum disorder and matched healthy controls.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2026-06

Completion Date

2028-06

Last Updated

2026-04-29

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

MDMA

MDMA will be prepared as gelatine capsules containing 25 mg of pharmaceutically pure MDMA hydrochloride (Lipomed AG, Arlesheim, Switzerland) and mannitol filler. MDMA will be administered in a single dose of 100 mg (4 capsules of 25 mg MDMA)

DIAGNOSTIC_TEST

Placebo

Placebos will be prepared as identical gelatine capsules containing only mannitol filler.

Locations (1)

University Hospital Basel, Endocrinology, Diabetes and Metabolism

Basel, Switzerland